Alessandro Pulsoni, MD, is an Associate Professor of Hematology at the Sapienza University of Rome, Italy. Dr Pulsoni studied general medicine at St. Mary’s Hospital Medical School, London, UK, before achieving a degree in medicine and surgery from the University of Rome, Rome, Italy, in 1981. After this, Dr Pulsoni carried out postgraduate studies in clinical epidemiology, writing and reviewing epidemiological papers, at John Hopkin’s University, Baltimore, MD. Between 1987 and 1990, Dr Pulsoni worked as a General Practitioner at the Azienda Sanitaria Locale, Rome, Italy. He the joined the Institute of Hematology at the Sapienza University of Rome in 1990 and reached Associate Professor status in 2019.
During his career, Dr Pulsoni has authored and co-authored over 150 peer reviewed research papers.
Speaking on hairy cell leukemia & follicular lymphoma
Dr Pulsoni is involved in several clinical trials. These include the study of rituximab-lenalidomide versus rituximab alone as maintenance therapy in relapsed or refractory follicular lymphoma, a study investigating the role of central nervous system involvement in acute myeloid leukemia, and the MALIBU trial, which studies ibrutinib and rituximab in untreated marginal zone lymphomas. Dr Pulsoni’s recent research papers focus on developing new treatments for diseases such as Hodgkin lymphoma and hairy-cell leukemia.